Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress PLOW Q1 2026 Earnings Earnings Surge 161 Above Estimates as Profitability Surprises CBUS Q1 2026 Earnings Narrower Loss Beats Estimates as Shares Climb BKKT Q1 2026 Earnings Wide EPS Miss Disappoints Revenue Data Withheld OMER Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Stock Falls Sharply ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue QMCO Q1 2026 Earnings EPS Beats Estimates by 216 Stock Gains SAQ Q1 2026 Earnings Steep EPS Miss Clouds Outlook for BDC ONL Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines BTG Q1 2026 Earnings Earnings Beat Estimates Despite Stock Decline CRVL Q1 2026 Earnings CorVel Posts 061 EPS as Stock Gains 195